PEN

$0.00

(

+0.00%

)
Quote details

stock

Penumbra Inc

NYSE | PEN

253.51

USD

(

+0.00%

)

At Close (As of Jan 1, 1970)

$9.83B

Market Cap

66.67

P/E Ratio

3.78

EPS

$310.00

52 Week High

$203.72

52 Week Low

HEALTHCARE

Sector

PEN Chart

Recent Chart
Price Action

PEN Technicals

Tags:

PEN Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $755M
Total Revenue $1.2B
Cost Of Revenue $440M
Costof Goods And Services Sold $440M
Operating Income $9.3M
Selling General And Administrative $574M
Research And Development $95M
Operating Expenses $746M
Investment Income Net -
Net Interest Income $12M
Interest Income $14M
Interest Expense $1.4M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $24M
Income Before Tax $21M
Income Tax Expense $6.9M
Interest And Debt Expense -
Net Income From Continuing Operations $14M
Comprehensive Income Net Of Tax -
Ebit $22M
Ebitda $46M
Net Income $14M

Revenue & Profitability

Earnings Performance

PEN Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $1.5B
Total Current Assets $951M
Cash And Cash Equivalents At Carrying Value $324M
Cash And Short Term Investments $324M
Inventory $407M
Current Net Receivables $168M
Total Non Current Assets $582M
Property Plant Equipment $268M
Accumulated Depreciation Amortization Ppe -
Intangible Assets $6.5M
Intangible Assets Excluding Goodwill $6.5M
Goodwill $166M
Investments -
Long Term Investments -
Short Term Investments $16M
Other Current Assets $37M
Other Non Current Assets -
Total Liabilities $382M
Total Current Liabilities $158M
Current Accounts Payable $31M
Deferred Revenue -
Current Debt -
Short Term Debt $15M
Total Non Current Liabilities $224M
Capital Lease Obligations $223M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $223M
Other Current Liabilities $112M
Other Non Current Liabilities $15M
Total Shareholder Equity $1.2B
Treasury Stock -
Retained Earnings $60M
Common Stock $38K
Common Stock Shares Outstanding $39M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow $168M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $24M
Capital Expenditures $21M
Change In Receivables -
Change In Inventory -$66M
Profit Loss -
Cashflow From Investment $78M
Cashflow From Financing -$87M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$100M
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income $14M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $755M
Total Revenue $1.2B
Cost Of Revenue $440M
Costof Goods And Services Sold $440M
Operating Income $9.3M
Selling General And Administrative $574M
Research And Development $95M
Operating Expenses $746M
Investment Income Net -
Net Interest Income $12M
Interest Income $14M
Interest Expense $1.4M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $24M
Income Before Tax $21M
Income Tax Expense $6.9M
Interest And Debt Expense -
Net Income From Continuing Operations $14M
Comprehensive Income Net Of Tax -
Ebit $22M
Ebitda $46M
Net Income $14M

PEN Profile

Penumbra Inc Profile

Sector: HEALTHCARE

Industry: MEDICAL DEVICES

Penumbra, Inc. is a biotechnology-driven medical device company focused on transforming the treatment landscape for neurological and vascular conditions. Based in Alameda, California, Penumbra employs a global reach with operations across major markets, including the United States, Europe, Canada, and Australia. The company's dedication to innovation and quality underpins its portfolio of advanced therapeutic solutions, aimed at improving patient outcomes and enhancing clinician workflows, thereby solidifying its position as a key player within the medical technology sector.

YYAI
-50.60%
$0.09
BYND
-20.67%
$2.84
SCNX
+354.94%
$2.60
YDKG
+5.58%
$0.07
F
-0.72%
$12.34
CGBS
-39.47%
$0.03
VHAI
0.00%
$0.00
RGTI
+9.80%
$39.59
AIRE
+38.18%
$0.98
RIG
+13.74%
$3.89
TSLA
+2.28%
$448.98
VTYX
+70.98%
$6.60
NOK
+11.17%
$6.17
BURU
-5.27%
$0.34
QBTS
+13.81%
$31.06
NVDA
+1.04%
$182.16
T
-3.63%
$24.62
INTC
+3.35%
$38.15
MSAI
+101.73%
$1.35
ADAP
-3.44%
$0.07
AAL
+5.62%
$12.77
VIVK
+5.68%
$0.26
WTO
-7.04%
$0.06
IONZ
-14.59%
$3.98
BITF
+4.39%
$4.11
AREB
+75.34%
$3.77
AXDX
-61.36%
$0.03
IONQ
+7.06%
$59.37
DNN
+0.18%
$2.72
PLUG
-1.36%
$2.88
ABEV
+0.45%
$2.21
SMCI
-8.72%
$47.92
QUBT
+7.19%
$15.94
TLRY
+2.06%
$1.48
VZ
-3.51%
$38.40
GRAB
+1.77%
$5.72
SOFI
+3.27%
$28.08
RGTZ
-20.27%
$14.90
RBNE
+7.87%
$1.37
JOBY
+1.29%
$15.67
BBD
+1.51%
$3.35
RF
-0.04%
$24.10
CAN
+3.22%
$1.76
ETHD
-3.17%
$3.97
ACHR
+0.46%
$10.91
QS
+7.95%
$14.66
RMBL
+60.50%
$3.21
SGBX
+29.82%
$2.96
AMD
+2.06%
$234.99
ADD
-25.47%
$0.05
BTG
+0.38%
$5.23
VLY
+4.24%
$10.56
GPUS
-0.28%
$0.38
PLTR
+2.84%
$180.48
LAES
+5.92%
$5.72
RXRX
-0.34%
$5.73
SRM
+53.27%
$10.30
PFE
-0.20%
$24.67
TNGX
-12.24%
$7.60
BTBT
+3.62%
$3.72
AAPL
+0.43%
$259.58
AMC
-0.72%
$2.73
UUUU
-6.50%
$21.26
CIFR
+7.10%
$17.25
MARA
+0.36%
$19.22
WBD
+3.50%
$21.25
ONDS
+5.56%
$7.11
DVLT
+5.14%
$2.25
AMZN
+1.44%
$221.09
HPE
+0.43%
$23.19
NIO
+0.73%
$6.89
IREN
+7.77%
$55.86
IBIO
-8.63%
$1.27
CUTR
-10.19%
$0.09
KMI
-4.75%
$26.25
NVTS
+0.03%
$13.61
PBR
+0.93%
$11.84
WLGS
-5.57%
$0.04
SOUN
+2.70%
$18.23
LUV
-6.25%
$31.65
RR
+7.11%
$5.42
TE
-9.73%
$3.71
ETWO
0.00%
$3.30
SCWO
+32.07%
$0.48
SNAP
+1.28%
$7.87
RIVN
+1.31%
$13.09
BAC
+1.29%
$51.76
BTE
+5.28%
$2.39
APLD
+9.01%
$33.38
DNUT
+1.98%
$4.11
HOOD
+5.58%
$134.33
LUMN
+10.58%
$7.78
VALE
-0.52%
$11.46
AFMD
-34.94%
$0.18
NCLH
-0.63%
$23.48
ERIC
-0.31%
$9.48
CLSK
+4.80%
$17.67
KDLY
+10.41%
$0.79
NAKA
+10.41%
$0.79
SMR
+8.17%
$37.56
YYAI
-50.60%
$0.09
BYND
-20.67%
$2.84
SCNX
+354.94%
$2.60
YDKG
+5.58%
$0.07
F
-0.72%
$12.34
CGBS
-39.47%
$0.03
VHAI
0.00%
$0.00
RGTI
+9.80%
$39.59
AIRE
+38.18%
$0.98
RIG
+13.74%
$3.89
TSLA
+2.28%
$448.98
VTYX
+70.98%
$6.60
NOK
+11.17%
$6.17
BURU
-5.27%
$0.34
QBTS
+13.81%
$31.06
NVDA
+1.04%
$182.16
T
-3.63%
$24.62
INTC
+3.35%
$38.15
MSAI
+101.73%
$1.35
ADAP
-3.44%
$0.07
AAL
+5.62%
$12.77
VIVK
+5.68%
$0.26
WTO
-7.04%
$0.06
IONZ
-14.59%
$3.98
BITF
+4.39%
$4.11
AREB
+75.34%
$3.77
AXDX
-61.36%
$0.03
IONQ
+7.06%
$59.37
DNN
+0.18%
$2.72
PLUG
-1.36%
$2.88
ABEV
+0.45%
$2.21
SMCI
-8.72%
$47.92
QUBT
+7.19%
$15.94
TLRY
+2.06%
$1.48
VZ
-3.51%
$38.40
GRAB
+1.77%
$5.72
SOFI
+3.27%
$28.08
RGTZ
-20.27%
$14.90
RBNE
+7.87%
$1.37
JOBY
+1.29%
$15.67
BBD
+1.51%
$3.35
RF
-0.04%
$24.10
CAN
+3.22%
$1.76
ETHD
-3.17%
$3.97
ACHR
+0.46%
$10.91
QS
+7.95%
$14.66
RMBL
+60.50%
$3.21
SGBX
+29.82%
$2.96
AMD
+2.06%
$234.99
ADD
-25.47%
$0.05
BTG
+0.38%
$5.23
VLY
+4.24%
$10.56
GPUS
-0.28%
$0.38
PLTR
+2.84%
$180.48
LAES
+5.92%
$5.72
RXRX
-0.34%
$5.73
SRM
+53.27%
$10.30
PFE
-0.20%
$24.67
TNGX
-12.24%
$7.60
BTBT
+3.62%
$3.72
AAPL
+0.43%
$259.58
AMC
-0.72%
$2.73
UUUU
-6.50%
$21.26
CIFR
+7.10%
$17.25
MARA
+0.36%
$19.22
WBD
+3.50%
$21.25
ONDS
+5.56%
$7.11
DVLT
+5.14%
$2.25
AMZN
+1.44%
$221.09
HPE
+0.43%
$23.19
NIO
+0.73%
$6.89
IREN
+7.77%
$55.86
IBIO
-8.63%
$1.27
CUTR
-10.19%
$0.09
KMI
-4.75%
$26.25
NVTS
+0.03%
$13.61
PBR
+0.93%
$11.84
WLGS
-5.57%
$0.04
SOUN
+2.70%
$18.23
LUV
-6.25%
$31.65
RR
+7.11%
$5.42
TE
-9.73%
$3.71
ETWO
0.00%
$3.30
SCWO
+32.07%
$0.48
SNAP
+1.28%
$7.87
RIVN
+1.31%
$13.09
BAC
+1.29%
$51.76
BTE
+5.28%
$2.39
APLD
+9.01%
$33.38
DNUT
+1.98%
$4.11
HOOD
+5.58%
$134.33
LUMN
+10.58%
$7.78
VALE
-0.52%
$11.46
AFMD
-34.94%
$0.18
NCLH
-0.63%
$23.48
ERIC
-0.31%
$9.48
CLSK
+4.80%
$17.67
KDLY
+10.41%
$0.79
NAKA
+10.41%
$0.79
SMR
+8.17%
$37.56

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.